Delivery Order SPE2DB20D3303-SPE2DB25FA0DW
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $13,872.63, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a respiratory medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,877.32, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 17, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,125.94 firm fixed-price contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty medication. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is associated with AmerisourceBergen's Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract has a ceiling value of $19,443.25 and is a firm fixed-price delivery order, with an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. The contract has a ceiling value of $2,583.60 and an ultimate completion date of May 22, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, with a ceiling value of $44,968.85 and a period of performance through January 21, 2025. The contract is a firm-fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,804.46, is for the provision of the pharmaceutical product PULMOZYME 1 MG/ML AMPUL 2.5ML. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and runs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,209.25, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,564.12 and a completion date of March 13, 2025. It is a firm fixed-price contract for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,096.22, is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a period of performance through January 29, 2025. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...